‘AI lowers the capital needed’: India’s drug discovery push faces test of human trials
- Asia Indian scientists and biopharmaceutical firms are using artificial intelligence to identify promising drug candidates faster and at lower cost.
- But industry experts tell CNA the technology can address only part of a lengthy and risky development process.
- A researcher working in the vaccine laboratory of Panacea Biotec, a pharmaceutical company in New Delhi, on Jan 29, 2026.
Unverified
- Asia Indian scientists and biopharmaceutical firms are using artificial intelligence to identify promising drug candidates faster and at lower cost.
- But industry experts tell CNA the technology can address only part of a lengthy and risky development process.
- A researcher working in the vaccine laboratory of Panacea Biotec, a pharmaceutical company in New Delhi, on Jan 29, 2026.
Sources: CNA